Colonic perforation with intraluminal stents and bevacizumab in advanced colorectal cancer: retrospective case series and literature review.
作者： Amal Imbulgoda , Anthony MacLean , John Heine , Sebastien Drolet , Michael Vickers
DOI: 10.1503/CJS.013014
关键词:
摘要: Background Self-expanding metal stents (SEMS) are increasingly used in the treatment of malignant large bowel obstruction setting inoperable colorectal cancer. Perforation is a well-known complication associated with these devices. The addition vascular endothelial growth factor inhibitor bevacizumab suspected to increase rate, but extent not known.
sci-hub.se 参考文章(25)
Fairooz F. Kabbinavar, Patrick J. Flynn, Mark Kozloff, Mark A. Ashby, Amy Sing, Charles E. Barr, Axel Grothey, Gastrointestinal perforation associated with bevacizumab use in metastatic colorectal cancer: results from a large treatment observational cohort study. European Journal of Cancer. ,vol. 48, pp. 1126- 1132 ,(2012) , 10.1016/J.EJCA.2012.02.052
J. van Hooft, P. Fockens, A. Marinelli, R. Timmer, A. van Berkel, P. Bossuyt, W. Bemelman, Early closure of a multicenter randomized clinical trial of endoscopic stenting versus surgery for stage IV left-sided colorectal cancer. Endoskopie Heute. ,vol. 21, pp. 123- 131 ,(2008) , 10.1055/S-2008-1076845
Martin D. Zielinski, Amit Merchea, Stephanie F. Heller, Y. Nancy You, Emergency Management of Perforated Colon Cancers: How Aggressive Should We Be? Journal of Gastrointestinal Surgery. ,vol. 15, pp. 2232- 2238 ,(2011) , 10.1007/S11605-011-1674-8
Arundhati Datye, Jeff Hersh, Colonic perforation after stent placement for malignant colorectal obstruction – causes and contributing factors Minimally Invasive Therapy & Allied Technologies. ,vol. 20, pp. 133- 140 ,(2011) , 10.3109/13645706.2010.518787
E HAN, B MONK, What is the risk of bowel perforation associated with bevacizumab therapy in ovarian cancer Gynecologic Oncology. ,vol. 105, pp. 3- 6 ,(2007) , 10.1016/J.YGYNO.2007.01.038
M. Karoui, A. Soprani, A. Charachon, C. Delbaldo, L. Vigano, A. Luciani, D. Cherqui, Primary chemotherapy with or without colonic stent for management of irresectable stage IV colorectal cancer. Ejso. ,vol. 36, pp. 58- 64 ,(2010) , 10.1016/J.EJSO.2009.10.011
Yunfei Cao, Aihua Tan, Feng Gao, Lidan Liu, Cun Liao, Zengnan Mo, A meta-analysis of randomized controlled trials comparing chemotherapy plus bevacizumab with chemotherapy alone in metastatic colorectal cancer International Journal of Colorectal Disease. ,vol. 24, pp. 677- 685 ,(2009) , 10.1007/S00384-009-0655-9
Barbara Bielawska, Lawrence C. Hookey, Diederick Jalink, Large-diameter self-expanding metal stents appear to be safe and effective for malignant colonic obstruction with and without concurrent use of chemotherapy Surgical Endoscopy. ,vol. 24, pp. 2814- 2821 ,(2010) , 10.1007/S00464-010-1055-5
Shaji Sebastian, Sean Johnston, Tony Geoghegan, William Torreggiani, Martin Buckley, Pooled analysis of the efficacy and safety of self-expanding metal stenting in malignant colorectal obstruction. The American Journal of Gastroenterology. ,vol. 99, pp. 2051- 2057 ,(2004) , 10.1111/J.1572-0241.2004.40017.X
Gloria Fernández-Esparrach, J M Bordas, M D Giráldez, A Ginès, M Pellisé, O Sendino, G Martínez-Pallí, A Castells, J Llach, Severe complications limit long-term clinical success of self-expanding metal stents in patients with obstructive colorectal cancer. The American Journal of Gastroenterology. ,vol. 105, pp. 1087- 1093 ,(2010) , 10.1038/AJG.2009.660